Marta Chesi

15.8k total citations · 2 hit papers
119 papers, 7.2k citations indexed

About

Marta Chesi is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Marta Chesi has authored 119 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Hematology, 84 papers in Molecular Biology and 35 papers in Oncology. Recurrent topics in Marta Chesi's work include Multiple Myeloma Research and Treatments (86 papers), Protein Degradation and Inhibitors (42 papers) and Ubiquitin and proteasome pathways (22 papers). Marta Chesi is often cited by papers focused on Multiple Myeloma Research and Treatments (86 papers), Protein Degradation and Inhibitors (42 papers) and Ubiquitin and proteasome pathways (22 papers). Marta Chesi collaborates with scholars based in United States, Canada and Australia. Marta Chesi's co-authors include P. Leif Bergsagel, W. Michael Kuehl, Leslie A. Brents, Elena Nardini, Rafaël Fonseca, Evelin Schröck, Thomas Ried, A. Keith Stewart, Victoria M. Garbitt and Robert Lim and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Marta Chesi

117 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

1997 525 citations Marta Chesi, Elena Nardini et al. Nature Genetics profile →
Clonal competition with alternating dominance in multiple myeloma

2012 456 citations Jonathan J. Keats, Marta Chesi et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marta Chesi United States	40	5.2k	4.0k	2.2k	943	817	119	7.2k
Norma C. Gutiérrez Spain	41	3.3k 0.6×	3.4k 0.9×	1.7k 0.8×	645 0.7×	1.2k 1.4×	179	5.6k
Jérôme Moreaux France	40	2.9k 0.6×	1.9k 0.5×	1.5k 0.7×	1.1k 1.2×	379 0.5×	170	4.9k
Thierry Rème France	43	2.5k 0.5×	2.0k 0.5×	1.4k 0.6×	1.8k 1.9×	545 0.7×	102	5.4k
Jonathan J. Keats United States	35	3.1k 0.6×	2.1k 0.5×	1.3k 0.6×	707 0.7×	381 0.5×	124	4.5k
Peter D. Aplan United States	48	4.4k 0.8×	2.3k 0.6×	899 0.4×	1.1k 1.1×	617 0.8×	155	6.4k
A. Kate Sasser United States	24	1.8k 0.3×	1.7k 0.4×	2.6k 1.2×	1.0k 1.1×	893 1.1×	54	4.5k
Marcel Spaargaren Netherlands	43	3.1k 0.6×	1.0k 0.3×	1.4k 0.6×	1.2k 1.3×	1.2k 1.5×	98	5.8k
Cristina Mecucci Italy	47	4.1k 0.8×	5.7k 1.4×	1.5k 0.7×	1.3k 1.3×	2.5k 3.1×	265	9.5k
Erming Tian United States	25	2.4k 0.5×	1.9k 0.5×	1.5k 0.7×	361 0.4×	351 0.4×	64	3.8k
Thoas Fioretos Sweden	39	2.5k 0.5×	2.5k 0.6×	981 0.4×	503 0.5×	1.1k 1.4×	153	5.6k

Countries citing papers authored by Marta Chesi

Since Specialization

Citations

This map shows the geographic impact of Marta Chesi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Chesi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Chesi more than expected).

Fields of papers citing papers by Marta Chesi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Chesi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Chesi. The network helps show where Marta Chesi may publish in the future.

Co-authorship network of co-authors of Marta Chesi

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Chesi. A scholar is included among the top collaborators of Marta Chesi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Chesi. Marta Chesi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zordan, Paola, Matteo Grioni, Anna Tosi, et al.. (2025). Microbiome modulation uncouples efficacy and toxicity induced by immune checkpoint blockade in mouse multiple myeloma. Nature Communications. 16(1). 10384–10384.

Meermeier, Erin W., Joshua Epstein, Meaghen E. Sharik, et al.. (2025). An immunostimulatory CELMoD combination overcomes resistance to T-cell engagers caused by a high multiple myeloma burden. Blood. 146(25). 3072–3085. 2 indexed citations

Yao, Yao, Mehmet Samur, Eugenio Morelli, et al.. (2023). CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma. Blood. 141(23). 2841–2852. 17 indexed citations

Baughn, Linda B., Erik Jessen, Neeraj Sharma, et al.. (2023). Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma. Blood Cancer Journal. 13(1). 84–84. 4 indexed citations

Meermeier, Erin W., Seth J. Welsh, Meaghen E. Sharik, et al.. (2021). Tumor Burden Limits Bispecific Antibody Efficacy through T-cell Exhaustion Averted by Concurrent Cytotoxic Therapy. Blood Cancer Discovery. 2(4). 354–369. 67 indexed citations

Robinson, Reeder M., Leticia Reyes, Allen B. Reitz, et al.. (2018). Inhibitors of the protein disulfide isomerase family for the treatment of multiple myeloma. Leukemia. 33(4). 1011–1022. 42 indexed citations

Pawlyn, Charlotte, Michael D. Bright, Amy Buros, et al.. (2017). Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control. Blood Cancer Journal. 7(3). e549–e549. 81 indexed citations

Bianco, Mimma, Anna Maria Gasparri, Barbara Colombo, et al.. (2016). Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients. Cancer Research. 76(7). 1781–1791. 20 indexed citations

Jensen, Jeffrey L., Alexander L. Rakhmilevich, Erika Héninger, et al.. (2015). Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma. Cancer Immunology Research. 3(8). 881–890. 22 indexed citations

10.

Bordini, Jessica, Maria Teresa Sabrina Bertilaccio, Maurilio Ponzoni, et al.. (2015). Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma. Haematologica. 100(6). 534–841. 18 indexed citations

11.

Calcinotto, Arianna, Maurilio Ponzoni, Roberto Ria, et al.. (2015). Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma. OncoImmunology. 4(6). e1008850–e1008850. 27 indexed citations

12.

Westwood, Jennifer A., Geoffrey M. Matthews, Jake Shortt, et al.. (2014). Combination anti-CD137 and anti-CD40 antibody therapy in murine myc-driven hematological cancers. Leukemia Research. 38(8). 948–954. 14 indexed citations

13.

Munugalavadla, Veerendra, Sanjeev Mariathasan, Dionysos Slaga, et al.. (2013). The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma. Oncogene. 33(3). 316–325. 37 indexed citations

14.

Keats, Jonathan J., Marta Chesi, Jan B. Egan, et al.. (2012). Clonal competition with alternating dominance in multiple myeloma. Blood. 120(5). 1067–1076. 456 indexed citations breakdown →

15.

Tiedemann, Rodger E., Xinliang Mao, Chang‐Xin Shi, et al.. (2008). Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity. Journal of Clinical Investigation. 118(5). 1750–64. 54 indexed citations

16.

Chesi, Marta, Davide F. Robbiani, Michaël Sébag, et al.. (2008). AID-Dependent Activation of a MYC Transgene Induces Multiple Myeloma in a Conditional Mouse Model of Post-Germinal Center Malignancies. Cancer Cell. 13(2). 167–180. 259 indexed citations

17.

Cao, Shanjin, Jianguo Liu, Marta Chesi, et al.. (2002). Differential Regulation of IL-12 and IL-10 Gene Expression in Macrophages by the Basic Leucine Zipper Transcription Factor c-Maf Fibrosarcoma. The Journal of Immunology. 169(10). 5715–5725. 100 indexed citations

18.

Gabrea, Ana, P. Leif Bergsagel, Marta Chesi, Yaping Shou, & W. Michael Kuehl. (1999). Insertion of Excised IgH Switch Sequences Causes Overexpression of Cyclin D1 in a Myeloma Tumor Cell. Molecular Cell. 3(1). 119–123. 85 indexed citations

19.

Chesi, Marta, Elena Nardini, Leslie A. Brents, et al.. (1997). Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nature Genetics. 16(3). 260–264. 525 indexed citations breakdown →

20.

Kuehl, W. Michael, Leslie A. Brents, Marta Chesi, Konrad Hüppi, & P. Leif Bergsagel. (1997). Dysregulation of c-myc in Multiple Myeloma. Current topics in microbiology and immunology. 224. 277–282. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact